Novo Integrated Sciences Overview
- Year Founded
-
2000
- Status
-
Public
- Employees
-
230
- Stock Symbol
-
NVOS
- Investments
-
14
- Share Price
-
$0.30
- (As of Friday Closing)
Novo Integrated Sciences General Information
Description
Novo Integrated Sciences Inc is a medical care company. It provides specialized physiotherapy, chiropractic care, occupational therapy, eldercare, laser therapeutics, massage therapy, acupuncture, neurological functions, kinesiology, and others. It has two reportable segments: healthcare services which generates majority of the revenue, and product sales.
Contact Information
Website
www.novointegrated.comCorporate Office
- 11120 North East 2nd Street
- Suite 100
- Bellevue, WA 98004
- United States
Corporate Office
- 11120 North East 2nd Street
- Suite 100
- Bellevue, WA 98004
- United States
Novo Integrated Sciences Timeline
Novo Integrated Sciences Stock Performance
(As of Friday Closing)
Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
---|---|---|---|---|---|---|
$0.30 | $0.30 | $0.20 - $5.29 | $5.79M | 19.1M | 1.06M | -$1.33 |
Novo Integrated Sciences Financials Summary
In Thousands, USD |
TTM 31-May-2024 | FY 2023 31-Aug-2023 | FY 2022 31-Aug-2022 | FY 2021 31-Aug-2021 |
---|---|---|---|---|
EV | 24,399 | 25,901 | 60,316 | 43,508 |
Revenue | 13,517 | 12,572 | 11,738 | 9,305 |
EBITDA | (16,026) | (5,858) | (22,649) | (2,627) |
Net Income | (24,329) | (13,215) | (32,849) | (4,462) |
Total Assets | 35,327 | 35,563 | 40,873 | 61,958 |
Total Debt | 4,502 | 4,472 | 12,996 | 13,708 |
Novo Integrated Sciences Valuation & Funding
Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
---|
Novo Integrated Sciences Comparisons
Industry
Financing
Details
Novo Integrated Sciences Competitors (1)
Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
---|---|---|---|---|---|---|
Georgia Spinal Health | Corporation | Fort Oglethorpe, GA |
Novo Integrated Sciences Patents
Novo Integrated Sciences Recent Patent Activity
Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
---|---|---|---|---|---|
CA-3226964-A1 | System and method to produce atmospheric nutritional and disinfectant iodine | Pending | 28-Jul-2021 | 00000000 | |
EP-4376901-A1 | System and method to produce atmospheric nutritional and disinfectant iodine | Pending | 28-Jul-2021 | 00000000 | |
US-20240252710-A1 | System and method to produce atmospheric nutritional and disinfectant iodine | Pending | 28-Jul-2021 | 00000000 | |
CA-3226961-A1 | System and method for airless aqueous iodine production | Pending | 26-Jul-2021 | 000000000 | |
EP-4376618-A1 | System and method for airless aqueous iodine production | Pending | 26-Jul-2021 | B01F25/32 |
Novo Integrated Sciences Executive Team (6)
Name | Title | Board Seat |
---|---|---|
Chris David | President, Chief Operating Officer, Executive, Investor Relations Officer & Board Member | |
Indrajit Sinha | Chief Science Officer | |
Robert Mattacchione | Chief Executive Officer & Board Chairman |
Novo Integrated Sciences Board Members (4)
Name | Representing | Role | Since |
---|---|---|---|
0000000 0000 | Self | Board Member | 000 0000 |
000000 00000000000 | Self | Chief Executive Officer & Board Chairman | 000 0000 |
00000000 000 | Self | Board Member | 000 0000 |
Novo Integrated Sciences Signals
Novo Integrated Sciences Investments & Acquisitions (14)
Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
---|---|---|---|---|---|
Joint Venture (Novo Integrated Sciences / Farm 7 Group) | 15-Aug-2023 | 00000 0000 | Other Agriculture | 000000 00 | |
Swagcheck | 23-Dec-2022 | 0000000000 | Other Financial Services | ||
Clinical Consultants International | 05-Apr-2022 | 0000000000 | 00.00 | Practice Management (Healthcare) | 000000 00 |
12858461 Canada | 01-Mar-2022 | 0000000000 | 0000 | Clinics/Outpatient Services | 000000 00 |
Fairway Physiotherapy and Sports Injury Clinic | 01-Mar-2022 | Merger/Acquisition | 00000 | Clinics/Outpatient Services | 000000 00 |
Novo Integrated Sciences Subsidiaries (6)
Company Name | Industry | Location | Founded |
---|---|---|---|
Good Iodine Company | Pharmaceuticals | Miami, FL | 2017 |
Pro-Dip | Food Products | Suffern, NY | 0000 |
Fairway Physiotherapy and Sports Injury Clinic | Clinics/Outpatient Services | Thunder Bay, Canada | 0000 |
Clinical Consultants International | Practice Management (Healthcare) | Bellevue, WA | 0000 |
Acenzia | BPO/Outsource Services | Oldcastle, Canada | 0000 |
Novo Integrated Sciences Exits (1)
Company Name | Exit Date | Exit Type | Exit Size | Status | Buyers |
---|---|---|---|---|---|
Progressive Health and Rehabilitation | 19-Mar-2018 | 000000000000 | Completed |
|
Novo Integrated Sciences FAQs
-
When was Novo Integrated Sciences founded?
Novo Integrated Sciences was founded in 2000.
-
Who is the CEO of Novo Integrated Sciences?
Robert Mattacchione is the CEO of Novo Integrated Sciences.
-
Where is Novo Integrated Sciences headquartered?
Novo Integrated Sciences is headquartered in Bellevue, WA.
-
What is the size of Novo Integrated Sciences?
Novo Integrated Sciences has 230 total employees.
-
What industry is Novo Integrated Sciences in?
Novo Integrated Sciences’s primary industry is Clinics/Outpatient Services.
-
Is Novo Integrated Sciences a private or public company?
Novo Integrated Sciences is a Public company.
-
What is Novo Integrated Sciences’s stock symbol?
The ticker symbol for Novo Integrated Sciences is NVOS.
-
What is the current stock price of Novo Integrated Sciences?
As of 13-Sep-2024 the stock price of Novo Integrated Sciences is $0.30.
-
What is the current market cap of Novo Integrated Sciences?
The current market capitalization of Novo Integrated Sciences is $5.79M.
-
What is Novo Integrated Sciences’s current revenue?
The trailing twelve month revenue for Novo Integrated Sciences is $13.5M.
-
Who are Novo Integrated Sciences’s competitors?
Georgia Spinal Health is a competitor of Novo Integrated Sciences.
-
What is Novo Integrated Sciences’s annual earnings per share (EPS)?
Novo Integrated Sciences’s EPS for 12 months was -$1.33.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »